Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05740098 · ClinicalTrials.gov registry record · NA
Financial Incentives for Smoking Cessation Among Mothers
A NA study, sponsored by University of Vermont.
- Completed
- Registry status
- NA
- Development phase
- 198
- Enrollment target
NCT05740098: Completed NA study, sponsored by University of Vermont.
NCT05740098 is a NA study that has completed, run by University of Vermont. The registered enrollment target is 198 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05740098, a NA study, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- NA
- Development phase
- 198 participants
- Enrollment target
Study Summary
Investigators will examine whether adding financial incentives and nicotine replacement dual therapy to current best practices for smoking cessation (i.e. referral to counseling using a telephone quit line) increases cessation rates in mothers and reduces second-hand smoke exposure in children. While perhaps more expensive upfront compared to best practices alone, the investigators hypothesize that this treatment approach will be a more cost-effective cessation intervention.
Primary Outcome
Point prevalence abstinence will be defined as self-report of no smoking in the past 7 days, not even a puff, with biochemical verification via breath carbon monoxide (CO) and urine cotinine. Abstinence at the 12-week (end of treatment) and 24-week assessment will be compared between the three treatment arms.
Interventions
- BEHAVIORAL Financial Incentives
- DRUG Nicotine Replacement Therapy
- BEHAVIORAL Best Practices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2015-06 |
| Est. Completion | 2020-10 |
| Phase | NA |
What the finished NCT05740098 record still lists
NCT05740098 is an interventional study that assigns participants to a tested intervention. The registered 198 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 3 interventions - of which Financial Incentives is the first listed.
NCT05740098 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05740098 about?
NCT05740098 is a clinical study titled "Financial Incentives for Smoking Cessation Among Mothers". Investigators will examine whether adding financial incentives and nicotine replacement dual therapy to current best practices for smoking cessation (i.e. referral to counseling using a telephone quit line) increases cessation rates in mothers and reduces second-hand smoke exposure in children. Whil...
What is the current status of trial NCT05740098?
This trial is currently completed. It is a NA study. The enrollment target is 198 participants. The study started on 2015-06. Estimated completion is 2020-10.
What interventions are being tested in trial NCT05740098?
The interventions under investigation include: Financial Incentives (BEHAVIORAL), Nicotine Replacement Therapy (DRUG), Best Practices (BEHAVIORAL).
Who is sponsoring clinical trial NCT05740098?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05740098's enrollment target sits among peer trials
198 567th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05203328 · 198 participants · NA
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
- NCT05426967 · 198 participants · NA
rTMS for Military TBI-related Depression
- NCT05561114 · 198 participants · Phase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
- NCT05585190 · 198 participants · NA
Stand Up for Your Health with a Sit-stand Desk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia